Jakob Knudsen
Chief Executive Officer at VIROGATES A/S
Net worth: 118 355 $ as of 2024-03-30
Jakob Knudsen active positions
| Companies | Position | Start | End |
|---|---|---|---|
| EXPRES2ION BIOTECH HOLDING AB | Director/Board Member | 2017-03-31 | - |
| Independent Dir/Board Member | 2017-03-31 | - | |
| VIROGATES A/S | Chief Executive Officer | 2011-03-31 | - |
| Investor Relations Contact | - | - | |
ExpreS2ion Biotechnologies ApS
 ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology ExpreS2ion Biotechnologies ApS operates as a biotechnology company which engages in the field of protein production in Drosophila Schneider-2 cells. Its services include custom proteins and research & development reagents, process development, and feasibility studies. The company was founded by Charlotte Dyring, Martin Roland Jensen, and Willem Adriaan de Jongh in 2009 and is headquartered in Horsholm, Denmark. | Director/Board Member | - | - |
| Independent Dir/Board Member | - | - | |
| P.V. Fonden | Director/Board Member | - | - |
| Ingeniørsystem A/S | Director/Board Member | - | - |
| Jakob Knudsen Enkeltmandsvirksomhed | Director/Board Member | - | - |
Career history of Jakob Knudsen
Former positions of Jakob Knudsen
| Companies | Position | Start | End |
|---|---|---|---|
Egalet Ltd.
 Egalet Ltd. Pharmaceuticals: MajorHealth Technology Egalet Ltd. engages in manufacturing of basic pharmaceutical products. It focuses on the commercialization and development of abuse resistant formulations of opioids and other pain care drugs. The company was founded on July 15, 2010 and is headquartered in London, the United Kingdom. | Director of Finance/CFO | 2008-01-31 | 2011-03-31 |
| ALK-ABELLÓ A/S | Corporate Officer/Principal | 1999-08-31 | 2008-01-31 |
Training of Jakob Knudsen
| Imperial College London | Masters Business Admin |
| University of Copenhagen | Graduate Degree |
Statistics
International
| Denmark | 9 |
| United Kingdom | 3 |
Operational
| Director/Board Member | 5 |
| Independent Dir/Board Member | 2 |
| Director of Finance/CFO | 1 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| ALK-ABELLÓ A/S | Health Technology |
| VIROGATES A/S | Health Technology |
| EXPRES2ION BIOTECH HOLDING AB | Health Technology |
| Private companies | 5 |
|---|---|
Egalet Ltd.
Egalet Ltd. Pharmaceuticals: MajorHealth Technology Egalet Ltd. engages in manufacturing of basic pharmaceutical products. It focuses on the commercialization and development of abuse resistant formulations of opioids and other pain care drugs. The company was founded on July 15, 2010 and is headquartered in London, the United Kingdom. | Health Technology |
ExpreS2ion Biotechnologies ApS
ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology ExpreS2ion Biotechnologies ApS operates as a biotechnology company which engages in the field of protein production in Drosophila Schneider-2 cells. Its services include custom proteins and research & development reagents, process development, and feasibility studies. The company was founded by Charlotte Dyring, Martin Roland Jensen, and Willem Adriaan de Jongh in 2009 and is headquartered in Horsholm, Denmark. | Health Technology |
| Ingeniørsystem A/S | |
| P.V. Fonden | |
| Jakob Knudsen Enkeltmandsvirksomhed |
- Stock Market
- Insiders
- Jakob Knudsen
- Experience
